C111H122ClF3N30O11 — CID 159350288
4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoic acid;4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxyphenol;5-(2-chlorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(2,6-difluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(4-fluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;methyl 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoate;molecular hydrogen (PubChem CID 159350288) has the molecular formula C111H122ClF3N30O11 and a molecular weight of 2144.84 g/mol. Its IUPAC name is 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoic acid;4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxyphenol;5-(2-chlorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(2,6-difluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(4-fluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;methyl 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoate;molecular hydrogen.
| Compound Name | 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoic acid;4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxyphenol;5-(2-chlorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(2,6-difluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(4-fluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;methyl 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoate;molecular hydrogen |
|---|---|
| PubChem CID | 159350288 |
| Molecular Formula | C111H122ClF3N30O11 |
| Molecular Weight | 2144.84 g/mol |
| Exact Mass | 2142.95 |
| IUPAC Name | 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoic acid;4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxyphenol;5-(2-chlorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(2,6-difluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(4-fluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;methyl 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoate;molecular hydrogen |
| SMILES | COC(=O)c1ccc(Oc2cnc(N)c(-c3nc4ccc(C)cc4[nH]3)n2)cc1.Cc1ccc2nc(-c3nc(Oc4c(F)cccc4F)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(Oc4ccc(C(=O)O)cc4)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(Oc4ccc(F)cc4)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(Oc4ccc(O)cc4)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(Oc4ccccc4Cl)cnc3N)[nH]c2c1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H] |
| InChI | InChI=1S/C20H17N5O3.C19H15N5O3.C18H14ClN5O.C18H13F2N5O.C18H14FN5O.C18H15N5O2.17H2/c1-11-3-8-14-15(9-11)24-19(23-14)17-18(21)22-10-16(25-17)28-13-6-4-12(5-7-13)20(26)27-2;1-10-2-7-13-14(8-10)23-18(22-13)16-17(20)21-9-15(24-16)27-12-5-3-11(4-6-12)19(25)26;1-10-6-7-12-13(8-10)23-18(22-12)16-17(20)21-9-15(24-16)25-14-5-3-2-4-11(14)19;1-9-5-6-12-13(7-9)24-18(23-12)15-17(21)22-8-14(25-15)26-16-10(19)3-2-4-11(16)20;1-10-2-7-13-14(8-10)23-18(22-13)16-17(20)21-9-15(24-16)25-12-5-3-11(19)4-6-12;1-10-2-7-13-14(8-10)22-18(21-13)16-17(19)20-9-15(23-16)25-12-5-3-11(24)4-6-12;;;;;;;;;;;;;;;;;/h3-10H,1-2H3,(H2,21,22)(H,23,24);2-9H,1H3,(H2,20,21)(H,22,23)(H,25,26);2-9H,1H3,(H2,20,21)(H,22,23);2-8H,1H3,(H2,21,22)(H,23,24);2-9H,1H3,(H2,20,21)(H,22,23);2-9,24H,1H3,(H2,19,20)(H,21,22);17*1H |
| InChIKey | LHFVFKYKVQYZOT-UHFFFAOYSA-N |
| XLogP | 26.66 |
| TPSA | 622.09 Ų |
| H-Bond Donors | 14 |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 20 |
| Heavy Atoms | 156 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2144.84 |
| LogP ≤ 5 | 26.66 |
| H-Bond Donors ≤ 5 | 14 |
| H-Bond Acceptors ≤ 10 | 34 |